Lp(a) particles mold fibrin-binding properties of Apo(a) in size-dependent manner: A study with different-length recombinant Apo(a), native Lp(a), and monoclonal antibody

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 7, 2002, Pages 1232-1238

  Kang, Chantal ^a   Dominguez, Miguel ^a   Loyau, Stéphane ^a   Miyata, Toshiyuki ^b   Durlach, Vincent ^c   Anglés Cano, Edouard ^a  

^a INSERM   (France)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Apolipoprotein(a); Fibrin affinity; Fibrin surfaces; Lipoprotein(a); Plasminogen

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APOLIPOPROTEIN A; BINDING PROTEIN; FIBRIN; LIPOPROTEIN A; LYSINE; PLASMINOGEN;

ARTICLE; ATHEROMA; BINDING AFFINITY; BINDING SITE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RISK FACTOR; THROMBOSIS;

EID: 0036063992     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000021144.87870.C8     Document Type: Article

References (46)

1. Lipoprotein(a) and coronary heart disease
2. Protein composition of Lp(a) lipoprotein from human plasma
3. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
4. Partial amino acid sequence of apolipoprotein(a) shows that it homologous to plasminogen
5. A structural assessment of the apo(a) protein of human lipoprotein(a)
6. Molecular definition of the extreme size polymorphism in apolipoprotein(a)
7. Comparison of ligand-binding sites of modeled apo(a) kringle-like sequences in human apolipoprotein(a)
8. Evidence that the fibrinogen binding domain of apo(a) is outside the lysine binding site of kringle IV-10: A study involving naturally occurring lysine binding defective lipoprotein phenotypes
9. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a)
10. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclērosis in apolipoprotein(a) transgenic mice
11. A single point mutation (Trp72→Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a)
12. Heterogeneity of human lipoprotein(a) Lp(a): Cytochemical and biochemical studies on the interaction of two Lp(a) species with the LDL receptor
13. Lysine-binding heterogeneity of Lp(a): Consequences for fibrin binding and inhibition of plasminogen activation
14. Polymorphic forms of Lp(a) with different structural and functional properties: Cold-induced self-association and binding to fibrin and lysine-Sepharose
15. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
16. Lipoprotein(a) isoforms display differences in affinity for plasminogen-like binding to human mononuclear cells
17. Relation of serum lipoprotein(a) and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia
18. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: Evidence for the role of apo(a) gene in coronary heart disease
19. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: Prospective results from the Bruneck study
20. Kringles of the plasminogen-prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): Specificity of the fibrin-binding site
21. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells
22. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
23. A novel kringle-4 number based recombinant apo[a] standard for human apo[a] phenotyping
24. A sandwich ELISA based on anti-apo(a) and anti-apo B monoclonal antibodies for lipoprotein(a) measurement
25. Protein measurement with the Folin phenol reagent
26. Electroblotting of multiple gels: A single apparatus without buffer tank for rapid transfer of protein from polyacrylamide to nitrocellulose
27. Determinants of lipoprotein(a) assembly: A study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions
28. Plasminogen purification from human plasma by affinity chromatography
29. Characterization of the binding of plasminogen to fibrin surfaces: The role of carboxy-terminal lysines
30. Characterization of human plasminogen, II: Separation and partial characterization of different molecular forms of human plasminogen
31. Protein cell membrane iodination with a sparingly soluble chloramide, 1,2,4.6-tetrachloro-3α, 6α-diphenylglycoluril
32. Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: An in vitro study using plasma from children with idiopathic nephrotic syndrome
33. Multiple binding with identical linkage: A mechanism that explains the effects of lipoprotein(a) on fibrinolysis
34. Apolipoprotein(a) and plasminogen interactions with fibrin: A study with recombinant apolipoprotein(a) and isolated plasminogen fragments
35. Serum lipoprotein(a) levels in racially different populations
36. Apo(a) isoforms predict risk for coronary heart disease: A study in six populations
37. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Standford Five-City Project participants
38. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease
39. Apolipoprotein(a) isoforms and coronary heart disease in men: A nested case-control study
40. Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis?
41. The kringle V-protease domain is a fibrinogen binding region within apo(a)
42. Sulfhydryl compounds influence immunoreactivity, structure and functional aspects of lipoprotein(a)
43. Physical properties of recombinant apolipoprotein(a) and its association with LDL to form an Lp(a)-like complex
44. The structure of lipoprotein(a) and ligand-induced conformational changes
45. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: A potential biochemical link between thrombosis, atherosclerosis, and sulfhydryl compound metabolism